Click to Share

Filter News
Show All Results
News By Country
News By Tag
Medulloblastoma Remove

January 2022

Public Company News

Business Press Releases

Medulloblastoma Press Releases

Exclusive News
Topics Locations Industries Dates

By Curtana Pharmaceuticals
Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical company, today announced that it has signed an agreement with Catalent to support tablet formulation and manufacturing of Curtana's CT-179, a drug therapy for the treatment of.
By Curtana Pharmaceuticals
Data Presented in Oral Presentation at the SNO 6th Biennial Pediatric Neuro-Oncology Research Conference

Page updated every 10 minutes

Like PRLog?
Click to Share